CRIS Current Research Information System

SABATTINI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.195
AS - Asia 8.333
NA - Nord America 7.332
SA - Sud America 576
AF - Africa 445
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.146
IT - Italia 6.027
CN - Cina 2.203
SG - Singapore 2.162
VN - Vietnam 2.075
GB - Regno Unito 910
DE - Germania 601
SE - Svezia 548
HK - Hong Kong 523
FR - Francia 437
BR - Brasile 409
IN - India 333
NL - Olanda 330
KR - Corea 239
RU - Federazione Russa 238
BD - Bangladesh 195
JP - Giappone 176
FI - Finlandia 171
IE - Irlanda 164
UA - Ucraina 135
ZA - Sudafrica 127
CH - Svizzera 126
SC - Seychelles 96
TG - Togo 88
CI - Costa d'Avorio 87
MX - Messico 84
BG - Bulgaria 80
CA - Canada 74
AR - Argentina 63
ES - Italia 61
ID - Indonesia 60
PH - Filippine 51
EE - Estonia 49
AT - Austria 46
PL - Polonia 45
TW - Taiwan 42
BE - Belgio 40
AU - Australia 39
IQ - Iraq 37
PT - Portogallo 37
TH - Thailandia 37
JO - Giordania 36
CL - Cile 33
GR - Grecia 32
PK - Pakistan 31
TR - Turchia 27
EC - Ecuador 25
RO - Romania 23
LT - Lituania 21
CO - Colombia 17
SA - Arabia Saudita 16
UZ - Uzbekistan 15
HR - Croazia 13
PE - Perù 12
SI - Slovenia 12
HU - Ungheria 11
NZ - Nuova Zelanda 11
MY - Malesia 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 8
DK - Danimarca 7
MA - Marocco 7
NG - Nigeria 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
GE - Georgia 6
IL - Israele 6
JM - Giamaica 6
PY - Paraguay 6
TN - Tunisia 6
DZ - Algeria 5
IR - Iran 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
SM - San Marino 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
OM - Oman 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BS - Bahamas 2
GH - Ghana 2
MZ - Mozambico 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BJ - Benin 1
CG - Congo 1
CY - Cipro 1
Totale 26.906
Salva come PNG Salva come JPEG
Città #
Singapore 1.476
Ashburn 811
Southend 680
Milan 581
Hong Kong 501
Ho Chi Minh City 488
San Jose 488
Chandler 476
Fairfield 438
Hefei 423
Rome 389
Santa Clara 382
Hanoi 367
Bologna 364
Dong Ket 347
Ann Arbor 286
Beijing 247
Woodbridge 212
Seattle 207
Wilmington 206
Princeton 205
Seoul 195
Houston 188
Boardman 167
Dallas 165
Dublin 161
Cambridge 155
New York 148
Turin 146
Council Bluffs 139
Florence 137
Los Angeles 137
Helsinki 129
Lauterbourg 115
Naples 106
Tokyo 103
Frankfurt am Main 94
Lomé 88
Abidjan 86
Nanjing 80
Westminster 80
Sofia 77
Genoa 73
Padova 73
São Paulo 71
Guangzhou 66
Berlin 65
Buffalo 61
Brescia 58
Zurich 57
Da Nang 55
Haiphong 54
Palermo 54
Jacksonville 52
Jinan 52
Redondo Beach 52
Orem 48
Bari 46
Shenyang 45
Shanghai 44
Johannesburg 43
Medford 43
Redmond 42
Redwood City 40
Bengaluru 38
San Diego 38
Brussels 36
Dearborn 36
Amman 35
Changsha 35
Parma 35
Verona 35
Modena 34
Jakarta 33
London 33
Saint Petersburg 33
Munich 32
Phoenix 32
Nuremberg 31
Ancona 30
Des Moines 30
Tianjin 30
Hebei 29
Hyderabad 29
Amsterdam 26
Brooklyn 26
Lappeenranta 26
Messina 26
Monza 26
Paris 26
Hải Dương 25
Warsaw 25
Cesena 24
Hangzhou 24
Jiaxing 24
Moscow 24
San Francisco 24
Catania 23
Nanchang 23
Albuquerque 22
Totale 14.522
Salva come PNG Salva come JPEG
Nome #
Attività antitumorale di un nuovo farmaco in due casi di linfoma cutaneo felino non responsivi a lomustina 1.499
Indicatori istopatologici di prognosi nel mastocitoma cutaneo e viscerale del gatto 1.335
Aspetto citologico, grado istologico, margini chirurgici e immunoistochimica del mastocitoma canino: in aiuto al clinico 1.097
Grading citologico del mastocitoma cutaneo del cane 784
Istologia, immunoistochimica e c-Kit nel mastocitoma felino: quanto servono al clinico? 658
The 2-tier grading system identifies canine cutaneous and/or subcutaneous mast cell tumors with aggressive biological behavior regardless of growth model 384
Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications 328
Emangiosarcoma: aspetti istopatologici e marker diagnostici 322
Feline large granular lymphocyte lymphoma: An Italian Society of Veterinary Oncology (SIONCOV) retrospective study 307
Intraoperative methylene blue staining is effective as a single mapping technique in the identification of sentinel lymph nodes in dogs with low‐grade mast cell tumours 276
Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment 266
SIONCOV guidelines for diagnosis, staging, and treatment of feline intestinal lymphoma 261
Linee guida SIONCOV 2023 per diagnosi, stadiazione e trattamento del carcinoma uroteliale di vescica e uretra del cane 257
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumor: diagnostic and prognostic implications 249
Cytological differentiation between benign and malignant perianal gland proliferative lesions in dogs: a preliminary study 243
Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa 239
Environmental risk factors for the development of oral squamous cell carcinoma in cats 235
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery 233
Comparative Assessment of the Accuracy of Cytological and Histologic Biopsies in the Diagnosis of Canine Bone Lesions 224
An Evolutionary Cancer Epigenetic Approach Revealed DNA Hypermethylation of Ultra-Conserved Non-Coding Elements in Squamous Cell Carcinoma of Different Mammalian Species 221
Papillomavirus associated malignancies in dogs and cats 220
Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis 220
Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation-sensitive high-resolution melting analysis 217
Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision 216
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: A preliminary study 216
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy 209
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumours: diagnostic and prognostic implications. 209
Mastociti in circolo: semplici spettatori o partecipanti attivi? Controversie, diagnosi e prognosi della mastocitosi/mastocitemia felina 207
A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma 206
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors 206
Ultrasonographic honeycomb pattern of the spleen in cats: correlation with pathological diagnosis in 33 cases 204
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014) 202
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma 201
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma. 198
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study 197
Periarticular histiocytic sarcoma with heart metastasis in a cat 197
Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor 196
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers 195
Comparison of definitive-intent finely fractionated and palliative-intent coarsely fractionated radiotherapy as adjuvant treatment of feline microscopic injection-site sarcoma 191
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs 190
Adjuvant dose-intense versus metronomic chemotherapy for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study. 190
Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma 187
Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes 186
Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy 185
Enhanced therapeutic effect of APAVAC vaccine in combination with dose-intense chemotherapy in dogs with clinically-advanced multicentric indolent B-cell lymphoma. 183
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain 182
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy 176
Reclassification of 21 presumptive canine peripheral nerve sheath tumors (pnst) using a literature-based immunohistochemical panel 176
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma 176
Role of CT in the Staging of Colorectal Tumors: A Preliminary Study on 10 Dogs 173
Grading Cutaneous Mast Cell Tumors in Cats 173
Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes 172
Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell Tumors 172
Treatment of oral squamous cell carcinoma in a horse by surgical debulking followed by metronomic chemotherapy 172
Airway Remodeling in Feline Lungs 172
Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study 170
Clinical relevance of simultaneous histopathological grading of canine cutaneous mast cell tumors at first presentation: a retrospective study on 386 cases. 170
P16 immunostaining of canine squamous cell carcinomas is not associated with papillomaviral DNA 170
Clinical Features and Outcome of 79 Dogs With Digital Squamous Cell Carcinoma Undergoing Treatment: A SIONCOV Observational Study 169
A Retrospective Clinico-Pathologic Study of 35 Dogs with Urethral Transitional Cell Carcinoma Undergoing Treatment 168
Metastatic Adenocarcinoma of Unknown Primary Origin Presenting with Severe Lumbar Neuropathic Pain in a Dog 168
Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours 168
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy 165
Comparison of sonographic and CT findings for the identification of renal nodules in dogs and cats 164
Clinicopathologic features and biologic behavior of canine splenic nodules with stromal, histiocytic and lymphoid components 163
COMPARISONS AMONG COMPUTED TOMOGRAPHIC FEATURES OF ADIPOSE MASSES IN DOGS AND CATS 162
EGFR Expression is Predictive of Poor Prognosis in Feline Cutaneous Squamous Cell Carcinoma 160
Esperienze cliniche ed anatomopatologiche sulla c.d. Pancitopenia Neonatale del bovino. Nota preliminare 159
ASSESSMENT OF EGFR AND HER-2 EXPRESSION AND ERAS-STATUS IN CANINE GASTRIC TUMOURS 159
Chemo-switch improves outcome in surgically-removed, biologically aggressive canine hemangiosarcoma. 159
Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature 158
Histopathological findings and proliferative activity of canine sebaceous gland tumours with a predominant reserve cell population 157
Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis 157
Prognostic Significance of Kit Receptor Tyrosine Kinase Dysregulations in Feline Cutaneous Mast Cell Tumors 156
Immunohistochemical prognosticators in feline cutaneous and visceral mast cell tumors. 153
Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System 152
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model? 152
Immunohistochemical characterization of therapeutic targets in canine bladder cancer 151
SIONCOV 2022 guidelines for the treatment and histopathologic diagnosis of canine cutaneous and subcutaneous mast cell tumors 150
EGFR expression and air pollution carcinogenesis in canine primary lung tumours 149
EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival 149
Feline large granular lymphocyte lymphoma: an Italian Society of Veterinary Oncology (SIONCOV) retrospective study. 149
COMPARISON OF A HYPOFRACTIONATED VERSUS A FULL-COURSE RADIOTHERAPY PROTOCOL FOR THE TREATMENT OF MICROSCOPIC CUTANEOUS MAST CELL TUMOURS IN DOGS. 149
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy 149
Ultrasonographic features of intestinal lipogranulomatous lymphangitis in 10 dogs 147
Expression Profile of Twelve Transcripts as a Supporting Tool for the Molecular Characterization of Canine Cutaneous Mast Cell Tumors at Diagnosis: Association with Histological Grading and Clinical Staging 147
Prognosis following surgical excision in canine and feline malignant skin tumors: the role of the histological evaluation of margins. 147
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours 147
Combination of radiation therapy and a selective COX-2 inhibitor (firocoxib) in the treatment of canine nasal carcinomas 145
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective study 144
Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma 143
CLINICAL OUTCOME OF DOGS WITH UROTHELIAL CARCINOMA TREATED WITH DOSE-INTENSE CHEMOTHERAPY VERSUS RADIO-CHEMOTHERAPY: A SINGLE-INSTITUTIONAL PROSPECTIVE UNBLINDED STUDY. 142
A phase 2, single-arm, open-label clinical trial on adjuvant active immunotherapy in dogs with appendicular osteosarcoma undergoing amputation and chemotherapy 141
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma 140
Histological grading of canine mast cell tumor: is two better than three? 139
A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study 137
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma 136
Case report: Sublingual mucinosis in a dog 136
Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions 135
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide 135
Totale 23.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021594 0 0 0 0 0 0 0 0 0 0 0 594
2021/20222.035 172 94 90 190 243 168 73 139 105 118 351 292
2022/20232.707 248 362 158 282 162 282 110 174 415 119 264 131
2023/20241.840 109 193 111 125 142 221 151 121 76 198 192 201
2024/20254.750 361 582 365 371 639 269 428 230 205 324 301 675
2025/202610.887 728 1.225 883 730 1.089 547 1.051 539 2.035 813 685 562
Totale 27.378